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Within the emerging field of stem cells there is a need for an environment that can regulate cell activity, to
slow down differentiation or proliferation, in vitro or in vivo while remaining invisible to the immune
system. By creating a nanoenvironment surrounding PC12 cells, Schwann cells, and neural precursor cells
(NPCs), we were able to control the proliferation, elongation, differentiation, and maturation in vitro. We
extended the method, using self-assembling nanofiber scaffold (SAPNS), to living animals with implants in
the brain and spinal cord. Here we show that when cells are placed in a defined system we can delay their
proliferation, differentiation, and maturation depending on the density of the cell population, density of the
matrix, and the local environment. A combination of SAPNS and young cells can be implanted into the
central nervous system (CNS), eliminating the need for immunosuppressants.
Key words: Nanotechnology; Stem cells; PC12; Schwann cells; Neural precursors; Brain; Spinal cord;
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INTRODUCTION Scaffolds play a central role in organ regeneration
(10). They act as a template and guide for cell prolifera-
tion, cell differentiation, and tissue growth, as well as aWith the advent of nanotechnology we are entering a
new era of tissue and organ reconstruction. Fine control way to control the release of drugs at rates matching the
physiological need of the tissue (31). The surface of theof the nanodomain will allow for increased targeting of
cell placement and therapeutic delivery, amplified by scaffold provides a substrate for cell adhesion and mi-
gration, which can influence the survival of transplantedcell encapsulation and implantation. Small changes in
the cellular environment can lead to the activation of the cells or the invasion of cells from the surrounding tissue.
Although many promising strategies have been devel-apoptotic pathway or even necrosis of the cells weeks
after implantation. oped for controlling the release of drugs from scaffolds,
there are still challenges to be addressed for these scaf-The successful storage and implantation of stem cells
poses significant challenges for tissue engineering in the folds to serve as successful treatments (23,45,56,59,60):
(a) precise placement of the cells into the scaffold tonervous system. This is in addition to the challenges in-
herent to neural regeneration: formation of the glial scar prevent migration from the scaffold before it has been
repopulated; (b) ability of the scaffold to allow cells tothat surrounds the lesions caused by traumatic brain in-
jury (TBI) or stroke, and the cystic cavities in spinal migrate into it, in order to reconstitute the tissue from
the surrounding area; and (c) prevention of the acidiccord injury (SCI) (12).
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breakdown of the cell scaffold, which results in an ad- (lactic-co-glycolic) acid (PLGA) (2,28,30,38,51); and
poly(2-hydroxyethyl methacrylate-co-methyl methacryl-verse environment for cell growth.
Many types of scaffolds, utilizing a wide range of ate) (pHEMA-MMA) (3,5,37,53,54). PLAs, PLGAs,
and MMAs have recently been used to form scaffoldsmaterials, have been used for the regeneration and repair
of the nervous system (47,58). In treating TBI or SCI preimpregnated with cells (36); the entire scaffold is
then implanted in the damaged tissue area (16).drug-delivering scaffolds may need to be combined with
cell transplantation to obtain functional recovery (56). Benefits. Synthetic materials have many advantages
for use as scaffolds. These polymers can be tailored to
TYPES OF SCAFFOLDS produce a wide range of mechanical properties and deg-
Natural Materials radation rates. They also have known compositions and
can be designed to minimize the immune response. Fi-Natural materials can impart intrinsic signals within
nally, synthetic polymers can be reacted together tothe structure that can enhance tissue formation (46).
combine the properties that are unique to each (55).They include alginate (26,27,41), chitosan (6,13,14),
collagen (1,34), fibrin (21,42–44,48–50), and hyaluron Drawbacks. Degradation by-products can be ab-
(18,19,24,52). sorbed by the body and may cause pH changes around
the implantation site, leading to necrosis and delayedBenefits. Natural materials possess many properties
apoptosis (55).that make them attractive for tissue applications. Many
of these materials contain sites for cell adhesion, allow- Synthetic Biological Materials
ing for cell attachment. These materials also exhibit sim- The next generation of cell scaffolds to emerge areilar properties to the tissues they are replacing (55). designed self-assembling peptides that spontaneously
Drawbacks. Because these materials are obtained form nanofibers (23,58–61), creating a scaffold-like tis-
from natural sources, they must be purified to ensure sue-bridging structure that provides a framework for
that no foreign body response occurs after implantation. axonal regeneration (9). They are formed through the
Homogeneity of product between lots can be an issue assembly of ionic self-complementary peptides (22,58–
with natural materials (55). In addition, (a) chitosan can 61) and are designed by using alternating positive and
cause an allergic reaction (20); (b) fibrin, from blood negative L-amino acids that form highly hydrated scaf-
products, and collagen, from animal products, have been folds in the presence of physiological concentration salts
known to cause an immune response (55); (c) some, but (i.e., saline, tissue culture media, physiological solu-
not all, natural materials allow for cell infiltration (55); tions, or human body fluids such as cerebrospinal fluid)
(d) the modulus of these materials may be very different (22,59,60). Because these scaffolds assemble using
from that of the tissue they are implanted in (8). In a weak ionic bonds and van der Waal’s forces the scaf-
pulsatile environment the materials will shear away from folds are motile and able to disassemble and reassemble
the surrounding tissue, causing additional damage (8); in the nanodomain, depending on the charge change.
and (e) by creating an environment that will not move Benefits. Synthetic biological material allows for
in the same way as the surrounding tissues, the cells are high cell implantation densities and enables cells to mi-
subjected to an environment different from their native grate freely in and out of the scaffold and the surround-
one; this can lead to a very different expression pattern ing tissue. The material can also be designed to match
of genes, one that produces an extracellular environment the modulus of the surrounding tissue (8). There appears
that is not conducive to repair, possibly leading to the to be no immune response when the material is either
development of tissue unable to function like the origi- (a) prebuffered or (b) allows buffering by the surround-
nal tissue (32). ing tissue and liquid in the injury site (17). During
Recently, a flexible scaffold system has been devel- breakdown there is no decrease of pH in the local envi-
oped, utilizing both collagen and a synthetic component
ronment.
that can degrade by both hydrolysis and collagenase
Drawbacks. Making pure nanomaterials in largedegradation pathways, as well as support cell growth.
quantities can be difficult because the process involvesThis type of scaffold could possibly be used in soft tis-
putting molecules together one at a time. To do that with
sue applications (15).
high fidelity, in bulk, is a technological challenge (un-
published observations).Synthetic Materials
Synthetic materials have known compositions and Challenges in Developing Cellular Therapies
can be custom designed with specific properties (46). To successfully reconstruct tissues and organs, cellu-
They include poly(ethylene glycol) (PEG) (4,29,33,40); lar therapies must integrate into the injury site. For CNS
poly(lactic acid) (PLA)/poly(glycolic acid) (PGA)/poly- injuries regeneration is not just replacement but re-
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growth of the lost neuronal circuitry, followed by pro- MATERIALS AND METHODS
motion of plasticity of the spared and regenerated neu- Preparation of the SAPNS Solution
rons (9,56). The SAPNS solution was prepared by usingPC12 cells will change branching patterns and pro- RADA16-I dry powder (made in the Ellis-Behnke lab,
cess densities depending on the modulus of the scaffold. MIT peptide lab, or purchased from BD) and mixed inIf the modulus is less than 10 pascals (Pa) branching
an Eppendorf tube. The solution contained 5, 10, 20, ordecreases along with neurite density, whereas when the 30 mg of RADA16-I powder in 1 ml of Milli-Q water
modulus is between 100 and 1000 Pa branching is more (Millipore), mixed, then sonicated for 30 s and filtered;pronounced and the cells exhibit process outgrowth that
this produced 0.5%, 1%, 2%, or 3% SAPNS. We tookis longer, with more cells expressing neurite markers
extra care to ensure that the material was pure by mixing(32,39).
the powder into the liquid and letting it sit at room tem-Other issues associated with human embryonic stem perature for 1 month. An indication of its purity was that
cell lines include the use of culture systems that rely it remained clear and odorless.
on serum or feeder cell layers. There is a need for the
development of culture methods for human stem cells PC12 Cell Culture
that involve chemically defined media (56). The end
PC12 cells were purchased and plated in 10-cm poly-goal for cellular therapies would be to create cell lines
styrene dishes, grown in a mixture of Hams F12k me-for transplantation that do not require immune suppres-
dium with 10% horse serum and 2.5% fetal bovine se-sion of the patient (56).
rum (FBS). Penicillin and streptomyosin were added
Self-Assembling Nanofiber Scaffold (SAPNS) along with 2 mM of L-glutamine and 1.5 g/L of sodium
bicarbonate (32). Cells were used after passage six.We previously demonstrated that a self-assembling
Cells were removed with trypsin-EDTA for transfer topeptide nanofiber scaffold (SAPNS) (10), a solution
the SAPNS. The SAPNS was prebuffered using the cul-containing a series of amino acids that flows into an area
ture medium DMEM. The SAPNS at various concentra-and self-assembles into a scaffold upon contact with any
tions was placed in separate wells and DMEM wasionic solution, eliminated the formation of a scar, thus
added and changed in 1-, 10-, and 30-min intervals. Theallowing the permissive environment (7) necessary for
phenol red in the culture medium was used as an indica-regeneration and functional return of behavior in the
tor for a balanced pH condition. The cells were trans-brain. We performed additional work where cells were
ferred to 0.5%, 1%, or 2% SAPNS and implanted intofirst implanted in the material, then implanted into the
the material. On day 10 nerve growth factor (NGF) wasspinal cord (17). The local environment is usually irreg-
added to assess the viability of the cell after the prolifer-ular and it is important for a self-assembled cellular
ation delay. Cells were incubated at 37°C in 5% CO2.scaffold to be able to conform to that environment. In
Medium was changed every 3 days.an effective scaffold cells can be added after the material
has flowed into the local area, or it can first be premixed
Schwann Cells (SC)into the solution and then the entire material injected
into the area where it will conform to the irregular envi- The SCs were isolated as described elsewhere (35,
57). Briefly, the sciatic nerves from adult green fluores-ronment.
Here we show the importance of placing cells into a cent protein (GFP) transgenic Sprague-Dawley rats [“green
rat CZ-004” SD TgN (act-EGFP) OsbCZ-004] were dis-defined system within a three-dimensional (3D) environ-
ment, allowing better control over growth and differenti- associated and placed in culture dishes with DMEM/F12
(Gibco) supplemented with 10% FBS (Gibco). When theation in order to effectively mimic the extracellular ma-
trix both in vitro and in vivo. outgrowth of migratory cells (predominantly fibroblasts)
reached a near-confluent monolayer around the explantsThis article will discuss: (a) the appropriate concen-
tration of material based on the type of cells being im- (about 7 days), the explants were transferred to new cul-
ture dishes with fresh medium. After three to five suchplanted; (b) determining if the material needs to be pre-
buffered, or if the cells need to be precultured in the passages (3–5 weeks) the cells that emerged from the
explants were primarily SCs. The explants were thenmaterial before it is then injected into the lesion area;
(c) controlling the physical environment to make it more transferred to a 35-mm dish containing 1.25 µg/ml dis-
pase, 0.05% collagenase, and 15% FBS in DMEM/F12permissive for cell migration while at the same time
slowing, or even arresting, the proliferation, elongation, for incubation overnight at 37°C in 5% CO2. On the
following day the explants were dissociated and the cellsand differentiation of the implanted cells; and (d) modu-
lation of the immune system with a unique physical en- were plated onto poly-L-lysine (0.01%; Sigma, St.
Louis, MO)-coated dishes in DMEM/F12 with 10%vironment around the implant site.
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FBS. Later the cultures were refed with the same me- 1.5 mm below the surface, from the midline to a point
beyond the lateral margin of the superior colliculus (9).dium supplemented with 20 µg/ml pituitary extract
(Sigma) and 2 µM forskolin (Sigma) for dividing. When Animals were kept alive 30 days after surgery. During
surgery, eight animals were treated by injection into thethe SCs reached confluence they were rinsed in Ca2+-
and Mg2+-free Hanks balanced salt solute ion (CMF- brain wound of 10 µm of 1% SAPNS. Control animals
with the same lesions included eight injected with 10HBSS; Gibco) and briefly treated with 0.05% trypsin
(Gibco) and 0.02% EDTA (Gibco) in CMF-HBSS. Cells µm isotonic saline (9).
were washed twice in DMEM/F12 with 10% FBS and
Surgical Procedurestransferred into new dishes at a density of 2 × 106 cells
per 100-mm dish. When the cells reached confluence Thirty-two adult Sprague-Dawley rats (220–250 g)
again they were collected for transplantation. were used in this project. The rats were divided into six
groups: (1) SAPNS only, (2) uncultured SAPNS withNeural Precursor Cells (NPC) SCs group 1, 4, and 8 weeks, (3) precultured SAPNS-
The generation and characterization of embryonic SCs alone group 2 and 8 weeks. Group one had two
NPC cultures have been previously described (11,25). wild-type rats; groups two and three had six for each
The hippocampi of embryonic day 16 (E16) embryos of time point. Rats were anesthetized with ketamine (80
GFP-transgenic Sprague-Dawley rats were dissected in mg/kg) and xylazine (10 mg/kg).
cooled CMF-HBSS and dissociated mechanically. The A dorsal laminectomy on the sixth and seventh cervi-
cells were collected by centrifugation and resuspended cal vertebrae was performed. The dura was incised lon-
in DMEM/F12 supplemented with B27 supplement (2%, gitudinally and pulled laterally. A spinal cord dorsal col-
Gibco), N2 (1%, Gibco), epidermal growth factor (EGF, umn transection was made between C6 and C7, followed
20 ng/ml, Gibco), basic fibroblast growth factor (bFGF, by the removal of 1 mm of dorsal column tissue. Ten
20 ng/ml, Sigma), penicillin (100 U/ml), and streptomy- microliters of 1% SAPNS solution was injected into the
cin (100 µg/ml). The cells were adjusted to 1 × 105 cells/ lesion site or an equal volume of the cultured mixture
ml and introduced into culture flasks. Half of the me- of SAPNS and SCs, respectively, was transferred from
dium was replaced every 3 days. Typically the cells the culture dish into the lesion cavity. After treatment
were mechanically dissociated approximately once each the dura was closed. The muscle layers and skin were
week and reseeded at approximately 1 × 105 cells/ml and also closed with a suture. Manual bladder expression
then implanted into SAPNS of 1%, 2%, and 3% concen- was performed twice daily until recovery of the bladder
trations. Pictures were then taken at 5, 7, 9, 12, 15, and reflex.
34 days. This was repeated in a non-GFP-expressing cell All surgical procedures were approved by the Com-
line and pictures were taken at 3, 5, 7, and 9 days. mittee for the Use of Live Animals in Teaching and Re-
search at the University of Hong Kong and MIT animalSchwann Cells in 3D Culture Within the SAPNS
care committee.
Before transplantation the SCs, obtained from the
sciatic nerves of GFP rats, were cultured within 1% RESULTS
SAPNS scaffold. Briefly, the SCs were collected and In Vitro
finally adjusted to 5 × 105 cells/µl. Then, 1 µl of the cell
suspension was mixed with 9 µl of RADA16-I peptide; Primary Neurons. In a 3D environment of SAPNS
PC12 cells appeared to become senescent, and in serum-the mixture was gently and quickly plated to dish in
DMEM/F12 with 10% FBS. The medium was changed free (SF) condition, did not divide for 3 days in 0.5%
SAPNS concentration, or 5 days in 1% SAPNS. Whenat 1, 10, and 30 min after plating, and once every 3 days
during the following days. The images of living cells the cells reached the boundary of the SAPNS they pro-
liferated at the normal rate until they reached confluencewere taken by two-photon confocal microscope (Zeiss
LSM510 META, Jena, Germany). and then stopped dividing. This process was repeated
three times. Using 2% SAPNS concentration delayed
Young Animals proliferation of PC12 cells to day 7 in SF conditions.
Care was taken during implantation of cells not to allowIn vivo applications to brain wounds were carried out
by using 16 postnatal day 5 (P5) Syrian hamster pups, the culture medium to contact the cells during implanta-
tion in the culture. When NGF was added processesanesthetized with whole-body cooling. The scalp was
opened, and the optic tract within the superior colliculus extended normally, but with a SAPNS concentration-
dependant delay (Fig. 1). This was repeated in serumwas completely severed with a deep knife wound
through a slot cut in the cartilaginous skull, extending conditions; proliferation was only delayed 1 day past the
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Figure 1. (a) PC12 cells grown in 2% SAPNS and SF conditions, (b) 2% SAPNS and fetal bovine serum (FBS), (c) 1% SAPNS
and FBS. Nerve growth factor (NGF) was added at day 10. All pictures were taken at day 17 after fixation. Note the increase in
branching in the serum condition (b, c) and the increase in branch size in the higher modulus material (b). Scale bar: 20 µm.
control in the 0.5% condition, however in the higher were observed. After 5 days processes were observed
extending from the cell body. When SCs were implantedconcentrations of 1% and 2% division was observed at
days 3 and 5, respectively. in 2% SAPNS, process extension was not observed until
5 days post-SAPNS implantation. Both conditions wereFor SCs, at a concentration of 5,000 cells/µl, 3 days
postimplantation in 1% SAPNS in vitro, no processes in FBS. When the concentration of cells was increased
Figure 2. Number of processes per cell over time. All of the SF (black) conditions have less than four processes per cell, while
the conditions with FBS (red) have greater than six processes by day 15. As the concentration of the material increases, the modulus
of the material increases. Note: as the modulus increases so does the number of processes per cell over time. Circles, triangles, and
squares represent 3%, 2%, and 1%, respectively. Error bars indicate SE.
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Figure 3. Branches per process. The graph shows the percentage of processes that have branches in each of the conditions. Circles,
triangles, and squares represent 3%, 2%, and 1%, respectively. Error bars indicate SE.
Figure 4. Branched processes per cell. Note that in the 1% and 3% SF conditions the number of branched processes is less than
one. However, in 2% it reaches one. In all serum-added conditions the branched processes are over 1 after day 5 in the 1% and
2% serum-added conditions, and after day 7 in the 3% condition. Error bars indicate SE.
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cant differences. In SF conditions only 35% of the pro-
cesses were branched by day 15 and the serum added
had 58% of the total processes branched. If cells were
plated in 2% it took longer, up to 5–7 days before ob-
serving processes emerge. The processes continued to
grow up to 30 days.
In cells implanted in SAPNS at 3% concentration SF
conditions reached a maximum of 3.5 ± 1 processes per
cell by day 15 of culture. With serum added cells
reached a maximum of 11.5 ± 1 processes per cell by
day 12. Branching of the processes showed statistically
significant differences. In SF conditions only 22% of the
processes were branched by day 15; the serum added
had 48% of the total processes branched by day 12.
In all SF conditions the number of branched pro-
cesses per cell remained below 1. The serum-added con-
ditions after day 5 had more than one branched process
per cell. As the concentration of the SAPNS increased
there was an increase in the number of branches in the
serum conditions. The maximum number of branched
processes per cell reached was 5.5 ± 1, in the serum-added
condition 3% SAPNS condition at day 12 (Fig. 4).
In Vivo
Brain. In P5 hamsters cells migrated into the 1%
SAPNS implantation after transection in the superior
colliculus in seven out of eight cases. All controls had
cavities at 1 month survival in the location of the lesion
(Fig. 5).Figure 5. Parasagittal sections from animals 60 days postle-
sion and treatment. Arrows indicate the path and extent of Spinal Cord. One percent SAPNS implanted into theknife cut. Animals sacrificed 30 days postlesion cases (a) is a
spinal cord alone eliminated the cysts when there wassaline control and (b) is an example of the peptide scaffold-
enough CSF and other ionic material left in the surgicaltreated animals. Note the large gap in (a). In the peptide scaf-
fold treatment case (b) the gap is completely gone and tissue site to buffer the material when implanted at the lesion
has reconnected across the injury site. All peptide scaffold so- site. This was repeated twice (Fig. 6).
lution-treated cases appear to have reconnected at the site of
Schwann Cell Implantation Into the Spinal Cord.the lesion. Scale bar: 100 µm.
Cells mixed with unbuffered 1% SAPNS and directly
implanted showed apoptosis and necrosis (17) as well as
to 10,000 cells/µl, process formation was delayed to 5 a reduced cyst formation at 4 and 8 weeks, compared
days in the 1% SAPNS concentration. with untreated controls (Fig. 7).
Prebuffered 1% SAPNS with cells showed no cyst orNeural Precursor Cells. Cells implanted in SAPNS
cavity formation at 2 weeks or 8 weeks. Also, cells mi-at 1% concentration in SF conditions reached a maxi-
grated into and out of the implantation site and weremum of 3 ± 1 processes per cell by day 5 of culture.
evident at up to a centimeter from the lesion site (Fig. 8).With serum added they reached a maximum of 9 ± 1
processes per cell by day 7. Branching of the processes
DISCUSSIONshowed statistically significant differences. In SF condi-
tions only 28% of the processes were branched by day The ability to keep the cells forever young during
implantation is very important to the reconstitution of15 and the serum added had 45% of the total processes
branched (Figs. 2 and 3). tissue or organs being replaced. In the emerging field of
stem cells there is a need for an environment that canFor cells implanted in SAPNS at 2% concentration,
by day 9 of culture SF conditions reached a maximum be tuned to the needs of the cells to slow down the dif-
ferentiation or proliferation in vitro or in vivo while re-of 3 ± 1 processes per cell. With serum added, by day 9
it reached a maximum of 8 ± 1 processes per cell. maining invisible to the immune system. We have shown
that when cells are placed into a defined system we canBranching of the processes showed statistically signifi-
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Figure 6. Spinal cord with 1% SAPNS implanted after the removal of 1.5 mm of spinal cord. Note the lack of cyst and the
surrounding cells have migrated into the site (arrows). Scale bar: 200 µm.
delay their proliferation, differentiation, and maturation Surface Interaction
depending on the density of the cell population, density
of the matrix, and the local environment. This is done Using the analogy of inserting one’s hand into a bowl
of rice, the rice looks solid but the little grains of ricein a 3D environment that allows the benefits of cell ther-
apy to be more fully realized. move out of the way of the hand and then come back
around the wrist. SAPNS appears to work in a very sim-
Extracellular Matrix Mimic ilar fashion; it does not covalently bond but is held to-
gether by weak ionic and van der Waal’s interactions.This set of experiments points to new ways of think-
ing about cell therapy and how the modulus and the These interactions allow the material to self-assemble
along the hydrophobic backbone, and hydrophilic fin-breakdown of an implanted matrix affect the lesion and
perilesion environment. Due to the porosity of this mate- gers that stick out perpendicular to the direction of the
fiber. The edges of the fiber are exposed and when arial at the nanoscale, the ability for T cells to migrate
into the treated environment seems to be greatly reduced cell interacts with the fiber, it causes a destabilization of
the nanodomain at the contact point with the fiber. The(8,9,17). The body does not look at this material as a
foreign material; it actually treats the material as it fiber disassembles to allow the cell to migrate into it,
and then reassembles on the other side of the cell. Anwould treat the extracellular matrix. This extracellular
matrix mimic does some very interesting things, not analogy would be: the cell’s charge opens the door, the
cell walks through the door, and the door shuts behindonly to the implanted cells, but also to the surrounding
tissue, such as changing the interface between the tissue it. Then the next door opens, and so forth.
Because this is a dynamic process, and not a perma-and the implant where a scar would normally form.
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nent process, the assembly and disassembly of this mate- sponse is seen on day 7. In the lowest concentration the
response is seen at day 5. All of this, of course, is depen-rial is very important for the controlled access to the
environment. It is creating an area that is less dense, dent upon the volume of the SAPNS and the surface
area of the bolus. When implanted in vivo this is muchone that enables cells to migrate into this area. In early
development the density of the ECM is much lower than more pronounced, due to the limited ability of any mate-
rial to diffuse across the implant boundary The higherin the adult stage. This differential density allows for
migration in a directed fashion. The matrix dynamic can the concentration of the SAPNS in vivo, the slower it
will breakdown.be modulated by the density and the motility of the local
environment. The control of proliferation in PC12 cells is cell–cell
contact. When the cells grow to confluence they stop
Concentration-Dependent Response dividing. This appears to be the case when the cells are
implanted into the SAPNS at different concentrations.There also appears to be a concentration/modulus-
dependant growth rate of the neural precursor cells when This cell–cell mimic (SAPNS) controls the cell prolifer-
ation rate. The PC12 cells were able to grow normallyplaced in culture. In the presence of serum we observe
that the higher the modulus, the more overall processes after implantation in SAPNS. When NGF is added, nor-
mal transformation of the cells and neurite extension isper cell. In serum-free conditions we do not see the
modulus-dependant component in NPCs. The SAPNS observed. There are differences that need to be pointed
out: (a) the higher the concentration of the SAPNS theappears to slow the growth rate and differentiation of
the cells, thus allowing them to acclimate to the environ- slower the neurite extension (b) with the increased mod-
ulus of the material, due to concentration, our resultsment. This will be very important when the immune sys-
tem tries attacking the cells when placed in vivo. agree with Leach (32): the increase in density tends to
have an increase in branches; and (c) after adding NGFThe NPCs appear to grow, or not grow, depending
on the addition of the serum. With serum, the NPCs the morphology of growth changes, depending on the
modulus of the environment.exhibit a concentration-dependant change in the re-
sponse rate: the higher the concentration of SAPNS, the
Schwann Cells and NPCstighter the matrix. The ability of the serum to diffuse
into the SAPNS shows a concentration-dependant re- There appears to be a similar reaction to the concen-
tration of the material and the cell density that decreasessponse. In the 3% SAPNS concentration the number and
the branch formation of the processes from the cells is proliferation and differentiation. The fundamental change
in growth pattern gives us new directions for the manip-delayed until day 9; in the 2% concentration the re-
Figure 7. Schwann cells implanted into the spinal cord at 1, 4, and 8 weeks after implantation into the spinal cord. Disassociated
cells were mixed with 1% SAPNS and implanted immediately after removing part of the spinal cord. Note: at 4 and 8 weeks there
are several cysts where the low pH of the material may have caused the cyst formation and an acid shock. This is very similar to
that in other scaffolds during breakdown. The reduction in pH will cause cellular apoptosis. Scale bar: 500 µm.
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Figure 8. Prebuffered 1% SAPNS with Schwann cells implanted into the spinal cord. Left is 2 weeks and right is 8 weeks survival.
There is good integration and distinct lack of boundary. Scale bar: 200 µm.
ulation of the cell’s growth program and the local im- shown in Figure 7. When the SAPNS was injected into
the lesion site of the hamster the existing CSF was suffi-mune system. Because the body does not treat the
SAPNS as a foreign material, it can be used in a fashion cient for immediate buffering of the material. We did
not see the acid response, where the cells die over timesimilar to an early development ECM that allows for the
migration of support cells into a treated area, thus allow- during breakdown, because the SAPNS does not break
down acidically.ing for the reprogramming, delay of the growth pro-
gram, or protection of the implanted cells. Also, by ma-
nipulating the concentration of the implanted cells, the Serum Free
environment of early development can be mimicked, The fact that cells can survive in SF condition is very
and until the cells are signaled they will remain in stasis beneficial because it provides much greater control overfor an extended period.
the medium chosen to grow the cells in vitro, before
implanting them into a tissue. In culture, using disasso-pH Contribution
ciated hippocampal cells from embryonic animals, weThere is also a pH contribution to the delay of the
observe that the branching rates are lower in the SF con-differentiation and growth of the cells. If the material is ditions, signaling that the growth and differentiation of
not buffered properly then there will be an acid shock;
the cells is more controlled temporally. In every cell
the cells that are in the implant of SAPNS will slowly
type we have worked with SF branching is a fraction ofdisappear. This is shown in the spinal cord implant when
what we found for the serum-added condition.
the GFP SCs are mixed and implanted before they are
buffered; the appearances of cysts are an indication of
CONCLUSIONan acid shock.
In the first implant of SAPNS at 1% concentration By manipulating the cell density and SAPNS concen-
tration we can control the nanoenvironment surroundinginto a spinal cord without prebuffering, healing of the
cord was evident. The injection of the preassembled ma- PC12 cells, Schwann cells, and NPCs, and thereby we
can control the proliferation, elongation, differentiation,terial was made into a cavity that had a mixture of blood
and CSF that allowed for immediate buffering of the and maturation in vitro. We also extended the control of
the nano environment using SAPNS to implants in theSAPNS. During subsequent implantations of added cells
and SAPNS, the lesion site was free of blood and CSF brain and spinal cord without cells. Finally, we showed
that a combination of SAPNS and young cells can beand therefore did not allow for sufficient buffering of
the local environment. Buffered implantations are shown transplanted into a mammal, eliminating the need for
immunosuppressants.in Figures 5, 6, and 8; unbuffered implantations are
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